Zoetis (ZTS) returns

Pharmaceuticals · NYSE · Health Care

$79.72 +1.17% Close Oct 30, 2026 Live

Zoetis returns over 10 years

$1,000 invested in Zoetis ten years ago was worth $1,804 at the close on October 30, 2026, with dividends reinvested: an average return of 6.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

ZTS, $10,000 investedS&P 500 (SPY)
$20,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +14.9% — $1,149 -0.9%
3 months +5.6% — $1,056 +2.1%
Year to date -35.2% — $647.80 +11.7%
1 year -43.2% — $567.59 +12.4%
3 years -46.7% -18.9% $532.55 +88.5%
5 years -60.8% -17.1% $392.18 +76.0%
10 years +80.4% +6.1% $1,804 +316.6%

Zoetis return by calendar year

YearZTSS&P 500 (SPY)Difference
2026 to date -35.2% +11.7% -46.9%
2025 -21.8% +17.7% -39.5%
2024 -16.6% +24.9% -41.5%
2023 +35.9% +26.2% +9.7%
2022 -39.5% -18.2% -21.3%
2021 +48.3% +28.7% +19.5%
2020 +25.8% +18.4% +7.4%
2019 +55.7% +31.2% +24.5%
2018 +19.5% -4.6% +24.0%
2017 +35.5% +21.7% +13.8%
2016 +12.6% +12.0% +0.6%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: ZTS financials · ZTS valuation

No forecast, no recommendation. This page describes Zoetis from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.